Android Apple

Apellis Pharmaceuticals, Inc. (APLS): Among Hedge Funds' Top Biotech Stock Picks

By Yahoo! Finance   |   3 months ago
Apellis Pharmaceuticals, Inc. (APLS): Among Hedge Funds' Top Biotech Stock Picks

Insider Monkey analyzed the top biotech hedge funds and their stock picks, focusing on Apellis Pharmaceuticals, Inc. (NASDAQ:APLS). Biotech stocks are risky due to clinical trials' impact on stock returns, with average ROI for R&D at 4.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.